GB9314271D0 - Cell growth factor receptors - Google Patents
Cell growth factor receptorsInfo
- Publication number
- GB9314271D0 GB9314271D0 GB939314271A GB9314271A GB9314271D0 GB 9314271 D0 GB9314271 D0 GB 9314271D0 GB 939314271 A GB939314271 A GB 939314271A GB 9314271 A GB9314271 A GB 9314271A GB 9314271 D0 GB9314271 D0 GB 9314271D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- growth factor
- cell growth
- factor receptors
- receptors
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G01N33/5759—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939314271A GB9314271D0 (en) | 1993-07-09 | 1993-07-09 | Cell growth factor receptors |
| AU70810/94A AU7081094A (en) | 1993-07-09 | 1994-07-08 | Cell growth factor receptors |
| ZA944983A ZA944983B (en) | 1993-07-09 | 1994-07-08 | Cell growth factor receptors |
| PCT/GB1994/001480 WO1995002187A1 (en) | 1993-07-09 | 1994-07-08 | Cell growth factor receptors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939314271A GB9314271D0 (en) | 1993-07-09 | 1993-07-09 | Cell growth factor receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9314271D0 true GB9314271D0 (en) | 1993-08-18 |
Family
ID=10738572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB939314271A Pending GB9314271D0 (en) | 1993-07-09 | 1993-07-09 | Cell growth factor receptors |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU7081094A (en) |
| GB (1) | GB9314271D0 (en) |
| WO (1) | WO1995002187A1 (en) |
| ZA (1) | ZA944983B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6051397A (en) * | 1993-11-16 | 2000-04-18 | Max Planck Gesellschaft Zur Forderung Der Wissenschaften | DNA encoding MCK-10, a novel receptor tyrosine kinase |
| US5911995A (en) * | 1994-08-19 | 1999-06-15 | Regents Of The University Of Minnesota | EGF-genistein conjugates for the treatment of cancer |
| US5587459A (en) * | 1994-08-19 | 1996-12-24 | Regents Of The University Of Minnesota | Immunoconjugates comprising tyrosine kinase inhibitors |
| FR2780161B1 (en) * | 1998-06-17 | 2000-09-29 | Centre Nat Rech Scient | METHOD FOR EARLY DIAGNOSIS OF CANCER BASED ON THE SEARCH FOR AUTO-ANTIBODIES DIRECTED AGAINST THE CSK PROTEIN AND KIT FOR ITS IMPLEMENTATION |
| SI1454992T1 (en) * | 2003-03-07 | 2006-10-31 | Ist Naz Stud Cura Dei Tumori | Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| DK2006381T3 (en) | 2006-03-31 | 2016-02-22 | Chugai Pharmaceutical Co Ltd | PROCEDURE FOR REGULATING ANTIBODIES BLOOD PHARMACOKINETICS |
| DK2202245T3 (en) | 2007-09-26 | 2016-11-21 | Chugai Pharmaceutical Co Ltd | A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR |
| UA121453C2 (en) | 2008-04-11 | 2020-06-10 | Чугей Сейяку Кабусікі Кайся | METHOD OF PREPARATION OF PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY |
| KR102385507B1 (en) | 2010-11-30 | 2022-04-12 | 추가이 세이야쿠 가부시키가이샤 | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
| CA2827923C (en) | 2011-02-25 | 2021-11-23 | Chugai Seiyaku Kabushiki Kaisha | Fc.gamma.riib-specific fc antibody |
| EP2518157A1 (en) | 2011-04-26 | 2012-10-31 | Sanofi | Test Systems and methods for identifying a compound altering cellular DDR activity |
| JP6101205B2 (en) | 2011-08-23 | 2017-03-22 | 中外製薬株式会社 | Novel anti-DDR1 antibody having antitumor activity |
| TW201817745A (en) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | Therapeutic antigen-binding molecule having an FcRn binding domain that promotes antigen clearance |
| JP6322411B2 (en) | 2011-09-30 | 2018-05-09 | 中外製薬株式会社 | Antigen-binding molecules that promote the disappearance of antigens with multiple physiological activities |
| SG10201609301QA (en) | 2011-11-30 | 2016-12-29 | Chugai Pharmaceutical Co Ltd | Drug containing carrier into cell for forming immune complex |
| SG10201704849PA (en) | 2012-02-09 | 2017-07-28 | Chugai Pharmaceutical Co Ltd | Modified fc region of antibody |
| AU2013306700B2 (en) | 2012-08-24 | 2019-05-02 | Chugai Seiyaku Kabushiki Kaisha | FcgammaRIIb-specific Fc region variant |
| WO2014163101A1 (en) | 2013-04-02 | 2014-10-09 | 中外製薬株式会社 | Fc region variant |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8900529A (en) * | 1989-03-03 | 1990-10-01 | Eurodiagnostics B V | METHOD AND KIT FOR DETERMINING TYROSINE PHOSPHORYLATING AND DEPHOSPHORLING ACTIVITY. |
| CA2062377A1 (en) * | 1991-03-21 | 1992-09-22 | Mariano Barbacid | Method for detection of neuroactive substances |
-
1993
- 1993-07-09 GB GB939314271A patent/GB9314271D0/en active Pending
-
1994
- 1994-07-08 AU AU70810/94A patent/AU7081094A/en not_active Abandoned
- 1994-07-08 ZA ZA944983A patent/ZA944983B/en unknown
- 1994-07-08 WO PCT/GB1994/001480 patent/WO1995002187A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU7081094A (en) | 1995-02-06 |
| ZA944983B (en) | 1996-01-08 |
| WO1995002187A1 (en) | 1995-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9125623D0 (en) | Cell modification | |
| ZA935284B (en) | Photovoltaic cell | |
| IL125126A0 (en) | Electroconversion cell | |
| TW441662U (en) | Cell material structure | |
| EP0534416A3 (en) | Solar cell | |
| GB9314271D0 (en) | Cell growth factor receptors | |
| EP0534473A3 (en) | Solar cell | |
| AU4410893A (en) | Electrolytic cell | |
| EP0537730A3 (en) | Solar cell | |
| GB9311252D0 (en) | Cell growth regualtors | |
| ZA914783B (en) | Mast cell growth factor | |
| GB9206732D0 (en) | Photovoltaic cells | |
| SG52238A1 (en) | Haemopoietic growth factor antagonists | |
| IL102374A0 (en) | Nanocrystalline cell | |
| IL96902A0 (en) | T cell growth factor | |
| GB9225928D0 (en) | Growth factor | |
| GB9424232D0 (en) | Growth factor expression | |
| GB9107612D0 (en) | Cell culture | |
| GB9309833D0 (en) | Artificial flower arrangement | |
| EP0891372A4 (en) | Growth factor htter36 | |
| GB9425050D0 (en) | Cell line | |
| GB9225776D0 (en) | Cell line | |
| GB9213256D0 (en) | Cell | |
| GB9318528D0 (en) | Cell line | |
| GB9306945D0 (en) | Cell modification |